Net Loss Per Share

6 Months Ended

Jun. 30, 2025

Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 11 (Stock-based Compensation), (ii) the warrants described in Note 6 (Warrant Liabilities), and (iii) the earnout liabilities described in Note 7 (Earnout Liabilities). Each of these potential common shares are antidilutive since their conversion to common shares would decrease loss per share from continuing operations.

Basic and diluted net loss per share attributable to common stockholders is calculated as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Net loss attributable to holders of Common Stock	$	(6,652)	$	(18,101)	$	(39,233)	$	(33,279)
Basic weighted-average shares of Common Stock outstanding	103,206,882		90,678,183		99,949,214		90,504,845
Basic net loss per share for the period attributable to holders of Common Stock	$	(0.06)	$	(0.20)	$	(0.39)	$	(0.37)
Effect of dilutive securities:

Dilutive numerator	$	(6,652)	$	(18,101)	$	(39,233)	$	(33,279)

Diluted weighted-average Common Stock outstanding	103,206,882		90,678,183		99,949,214		90,504,845
Diluted net loss per share for the period attributable to holders of Common Stock	$	(0.06)	$	(0.20)	$	(0.39)	$	(0.37)

Additionally, the following securities were not included in the quarter-to-date or year-to-date computation of diluted shares outstanding because the effect would have been anti-dilutive:


	Three and Six Months Ended June 30,
	2025	2024
Warrants	49,184,815	49,184,915
Sponsor earnout shares	1,775,962	1,775,962
Stock options	1,995,277	4,702,325
Restricted stock units	3,564,199	3,017,253
Shares convertible from Secured Convertible Notes	25,000,000	25,000,000
Total	81,520,253	83,680,455